Grossbard ML - Search Results

1

CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. Treon SP, et al. Among authors: grossbard ml. J Immunother. 2002 Jan-Feb;25(1):72-81. doi: 10.1097/00002371-200201000-00008. J Immunother. 2002. PMID: 11924912 Clinical Trial.

2

Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.

Treon SP, Shima Y, Preffer FI, Doss DS, Ellman L, Schlossman RL, Grossbard ML, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: grossbard ml. Semin Oncol. 1999 Oct;26(5 Suppl 14):97-106. Semin Oncol. 1999. PMID: 10561024

3

Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens.

Treon SP, Shima Y, Grossbard ML, Preffer FI, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: grossbard ml. Ann Oncol. 2000;11 Suppl 1:107-11. Ann Oncol. 2000. PMID: 10707790 Review.

4

Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.

Grossbard ML, Fidias P, Kinsella J, O'Toole J, Lambert JM, Blattler WA, Esseltine D, Braman G, Nadler LM, Anderson KC. Grossbard ML, et al. Br J Haematol. 1998 Jul;102(2):509-15. doi: 10.1046/j.1365-2141.1998.00799.x. Br J Haematol. 1998. PMID: 9695966 Free article. Clinical Trial.

5

Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.

Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinowe SN, Anderson KC, Soiffer RJ, Spector N, Grossbard M, Robertson MJ, et al. Freedman AS, et al. J Clin Oncol. 1993 May;11(5):931-6. doi: 10.1200/JCO.1993.11.5.931. J Clin Oncol. 1993. PMID: 8487057 Clinical Trial.

6

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.

Howard OM, Gribben JG, Neuberg DS, Grossbard M, Poor C, Janicek MJ, Shipp MA. Howard OM, et al. J Clin Oncol. 2002 Mar 1;20(5):1288-94. doi: 10.1200/JCO.2002.20.5.1288. J Clin Oncol. 2002. PMID: 11870171 Clinical Trial.

7

The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R.

Wilson WH, Gutierrez M, O'Connor P, Frankel S, Jaffe E, Chabner BA, Grossbard ML. Wilson WH, et al. Among authors: grossbard ml. Semin Oncol. 2002 Feb;29(1 Suppl 2):41-7. Semin Oncol. 2002. PMID: 11842388 Clinical Trial.

8

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.

Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blättler WA, et al. Grossbard ML, et al. Blood. 1992 Feb 1;79(3):576-85. Blood. 1992. PMID: 1370636 Free article. Clinical Trial.

9

Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma.

Multani PS, O'Day S, Nadler LM, Grossbard ML. Multani PS, et al. Among authors: grossbard ml. Clin Cancer Res. 1998 Nov;4(11):2599-604. Clin Cancer Res. 1998. PMID: 9829722 Clinical Trial.

10

Empowering targeted therapy: lessons from rituximab.

Olszewski AJ, Grossbard ML. Olszewski AJ, et al. Among authors: grossbard ml. Sci STKE. 2004 Jul 6;2004(241):pe30. doi: 10.1126/stke.2412004pe30. Sci STKE. 2004. PMID: 15252219 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters